Top

Published in:

01-04-2001

Angiogenesis inhibitor TNP-470 reduces human pancreatic cancer growth

Authors: Hubert G. Hotz, M.D., Howard A. Reber, M.D., Birgit Hotz, Premal C. Sanghavi, M.D., Tina Yu, M.D., Thomas Foitzik, M.D., Heinz J. Buhr, M.D., Oscar J. Hines, M.D.

Published in: Journal of Gastrointestinal Surgery | Issue 2/2001

Title: Angiogenesis inhibitor TNP-470 reduces human pancreatic cancer growth
Authors: Hubert G. Hotz, M.D.
Howard A. Reber, M.D.
Birgit Hotz
Premal C. Sanghavi, M.D.
Tina Yu, M.D.
Thomas Foitzik, M.D.
Heinz J. Buhr, M.D.
Oscar J. Hines, M.D.
Publication date: 01-04-2001
Publisher: Springer-Verlag
Published in: Journal of Gastrointestinal Surgery / Issue 2/2001
Print ISSN: 1091-255X
Electronic ISSN: 1873-4626
DOI: https://doi.org/10.1016/S1091-255X(01)80024-X

2024 ASCO Annual Meeting

Springer Medicine

Angiogenesis inhibitor TNP-470 reduces human pancreatic cancer growth

2024 ASCO Annual Meeting

Springer Medicine

Please log in to get access to this content

Other articles of this Issue 2/2001

Synthetic peptide YY analog binds to a cell membrane receptor and delivers fluorescent dye to pancreatic cancer cells

Special problems in minimally invasive surgery of the foregut: Part I

Contribution of intraoperative enteroscopy in the management of obscure gastrointestinal bleeding

Therapy for pancreatic cancer with a recombinant humanized anti-HER2 antibody (herceptin)

Commentary

Effect of preoperative chemoradiotherapy on surgical margin status of resected adenocarcinoma of the head of the pancreas